nach oben

Cancer and Metastasis Reviews

Erschienen in:

11.10.2019

Spatio-temporal modeling and live-cell imaging of proteolysis in the 4D microenvironment of breast cancer

verfasst von: Kyungmin Ji, Mansoureh Sameni, Kingsley Osuala, Kamiar Moin, Raymond R. Mattingly, Bonnie F. Sloane

Erschienen in: Cancer and Metastasis Reviews | Ausgabe 3/2019

Einloggen, um Zugang zu erhalten

Abstract

Cells grown in three dimensions (3D) within natural extracellular matrices or synthetic scaffolds more closely recapitulate the phenotype of those cells within tissues in regard to normal developmental and pathobiological processes. This includes degradation of the surrounding stroma as the cells migrate and invade through the matrices. As 3D cultures of tumor cells predict efficacy of, and resistance to, a wide variety of cancer therapies, we employed tissue-engineering approaches to establish 3D pathomimetic avatars of human breast cancer cells alone and in the context of both their cellular and pathochemical microenvironments. We have shown that we can localize and quantify key parameters of malignant progression by live-cell imaging of the 3D avatars over time (4D). One surrogate for changes in malignant progression is matrix degradation, which can be localized and quantified by our live-cell proteolysis assay. This assay is predictive of changes in spatio-temporal and dynamic interactions among the co-cultured cells and changes in viability, proliferation, and malignant phenotype. Furthermore, our live-cell proteolysis assay measures the effect of small-molecule inhibitors of proteases and kinases, neutralizing or blocking antibodies to cytokines and photodynamic therapy on malignant progression. We suggest that 3D/4D pathomimetic avatars in combination with our live-cell proteolysis assays will be a useful preclinical screening platform for cancer therapies. Our ultimate goal is to develop 3D/4D avatars from an individual patient’s cancer in which we can screen “personalized medicine” therapies using changes in proteolytic activity to quantify therapeutic efficacy.

Debnath, J., & Brugge, J. S. (2005). Modelling glandular epithelial cancers in three-dimensional cultures. Nature Reviews. Cancer, 5(9), 675–688. https://doi.org/10.1038/nrc1695.CrossRefPubMed

Martin, K. J., Patrick, D. R., Bissell, M. J., & Fournier, M. V. (2008). Prognostic breast cancer signature identified from 3D culture model accurately predicts clinical outcome across independent datasets. PLoS One, 3(8), e2994. https://doi.org/10.1371/journal.pone.0002994.CrossRefPubMedPubMedCentral

Weigelt, B., Ghajar, C. M., & Bissell, M. J. (2014). The need for complex 3D culture models to unravel novel pathways and identify accurate biomarkers in breast cancer. Advanced Drug Delivery Reviews, 69-70, 42–51. https://doi.org/10.1016/j.addr.2014.01.001.CrossRefPubMed

Siegel, R. L., Miller, K. D., & Jemal, A. (2019). Cancer statistics, 2019. CA: a Cancer Journal for Clinicians, 69(1), 7–34. https://doi.org/10.3322/caac.21551.CrossRef

Li, Q., Mullins, S. R., Sloane, B. F., & Mattingly, R. R. (2008). p21-activated kinase 1 coordinates aberrant cell survival and pericellular proteolysis in a three-dimensional culture model for premalignant progression of human breast cancer. Neoplasia, 10(4), 314–329.CrossRefPubMedPubMedCentral

Li, Q., Chow, A. B., & Mattingly, R. R. (2010). Three-dimensional overlay culture models of human breast cancer reveal a critical sensitivity to mitogen-activated protein kinase kinase inhibitors. The Journal of Pharmacology and Experimental Therapeutics, 332(3), 821–828. https://doi.org/10.1124/jpet.109.160390.CrossRefPubMedPubMedCentral

Nam, J. M., Onodera, Y., Bissell, M. J., & Park, C. C. (2010). Breast cancer cells in three-dimensional culture display an enhanced radioresponse after coordinate targeting of integrin alpha5beta1 and fibronectin. Cancer Research, 70(13), 5238–5248. https://doi.org/10.1158/0008-5472.CAN-09-2319.CrossRefPubMedPubMedCentral

Maguire, S. L., Peck, B., Wai, P. T., Campbell, J., Barker, H., Gulati, A., Daley, F., Vyse, S., Huang, P., Lord, C. J., Farnie, G., Brennan, K., & Natrajan, R. (2016). Three-dimensional modelling identifies novel genetic dependencies associated with breast cancer progression in the isogenic MCF10 model. The Journal of Pathology, 240(3), 315–328. https://doi.org/10.1002/path.4778.CrossRefPubMed

Brock, E. J., Ji, K., Shah, S., Mattingly, R. R., & Sloane, B. F. (2019). In vitro models for studying invasive transitions of ductal carcinoma in situ. Journal of Mammary Gland Biology and Neoplasia, 24(1), 1–15. https://doi.org/10.1007/s10911-018-9405-3.CrossRefPubMed

10.

Herschkowitz, J. I., & Behbod, F. (2018). Advances in DCIS research and treatment. [journal issue]. Journal of Mammary Gland Biology and Neoplasia, 23 & 24, 1–301. https://doi.org/10.1007/s10911-018-9419-x.CrossRef

11.

Edwards, D., Hoyer-Hansen, G., Blasi, F., & Sloane, B. F. (2008). The cancer degradome: protease and cancer biology. New York: Springer.CrossRef

12.

Sloane, B. F., List, K., Fingleton, B., & Matrisian, L. (2013). Proteases: structure and function. New York: Springer.

13.

Darvishian, F., Ozerdem, U., Adams, S., Chun, J., Pirraglia, E., Kaplowitz, E., Guth, A., Axelrod, D., Shapiro, R., Price, A., Troxel, A., Schnabel, F., & Roses, D. (2019). Tumor-infiltrating lymphocytes in a contemporary cohort of women with ductal carcinoma in situ (DCIS). Annals of Surgical Oncology, 26(10), 3337–3343. https://doi.org/10.1245/s10434-019-07562-x.CrossRefPubMed

14.

Grugan, K. D., McCabe, F. L., Kinder, M., Greenplate, A. R., Harman, B. C., Ekert, J. E., van Rooijen, N., Anderson, G. M., Nemeth, J. A., Strohl, W. R., Jordan, R. E., & Brezski, R. J. (2012). Tumor-associated macrophages promote invasion while retaining Fc-dependent anti-tumor function. Journal of Immunology, 189(11), 5457–5466. https://doi.org/10.4049/jimmunol.1201889.CrossRef

15.

Shree, T., Olson, O. C., Elie, B. T., Kester, J. C., Garfall, A. L., Simpson, K., Bell-McGuinn, K. M., Zabor, E. C., Brogi, E., & Joyce, J. A. (2011). Macrophages and cathepsin proteases blunt chemotherapeutic response in breast cancer. Genes & Development, 25(23), 2465–2479. https://doi.org/10.1101/gad.180331.111.CrossRef

16.

Erdogan, B., & Webb, D. J. (2017). Cancer-associated fibroblasts modulate growth factor signaling and extracellular matrix remodeling to regulate tumor metastasis. Biochemical Society Transactions, 45(1), 229–236. https://doi.org/10.1042/BST20160387.CrossRefPubMedPubMedCentral

17.

Qiu, S. Q., Waaijer, S. J. H., Zwager, M. C., de Vries, E. G. E., van der Vegt, B., & Schroder, C. P. (2018). Tumor-associated macrophages in breast cancer: Innocent bystander or important player? Cancer Treatment Reviews, 70, 178–189. https://doi.org/10.1016/j.ctrv.2018.08.010.CrossRefPubMed

18.

Dawson, P. J., Wolman, S. R., Tait, L., Heppner, G. H., & Miller, F. R. (1996). MCF10AT: a model for the evolution of cancer from proliferative breast disease. The American Journal of Pathology, 148(1), 313–319.PubMedPubMedCentral

19.

Santner, S. J., Dawson, P. J., Tait, L., Soule, H. D., Eliason, J., Mohamed, A. N., Wolman, S. R., Heppner, G. H., & Miller, F. R. (2001). Malignant MCF10CA1 cell lines derived from premalignant human breast epithelial MCF10AT cells. Breast Cancer Research and Treatment, 65(2), 101–110.CrossRefPubMed

20.

Miller, F. R., Santner, S. J., Tait, L., & Dawson, P. J. (2000). MCF10DCIS.com xenograft model of human comedo ductal carcinoma in situ. Journal of the National Cancer Institute, 92(14), 1185–1186. https://doi.org/10.1093/jnci/92.14.1185a.CrossRefPubMed

21.

Sameni, M., Cavallo-Medved, D., Franco, O. E., Chalasani, A., Ji, K., Aggarwal, N., Anbalagan, A., Chen, X., Mattingly, R. R., Hayward, S. W., & Sloane, B. F. (2017). Pathomimetic avatars reveal divergent roles of microenvironment in invasive transition of ductal carcinoma in situ. Breast Cancer Research, 19(1), 56. https://doi.org/10.1186/s13058-017-0847-0.CrossRefPubMedPubMedCentral

22.

Polyak, K., & Hu, M. (2005). Do myoepithelial cells hold the key for breast tumor progression? Journal of Mammary Gland Biology and Neoplasia, 10(3), 231–247. https://doi.org/10.1007/s10911-005-9584-6.CrossRefPubMed

23.

Labernadie, A., Kato, T., Brugues, A., Serra-Picamal, X., Derzsi, S., Arwert, E., et al. (2017). A mechanically active heterotypic E-cadherin/N-cadherin adhesion enables fibroblasts to drive cancer cell invasion. Nature Cell Biology, 19(3), 224–237. https://doi.org/10.1038/ncb3478.CrossRefPubMedPubMedCentral

24.

Sameni, M., Tovar, E. A., Essenburg, C. J., Chalasani, A., Linklater, E. S., Borgman, A., Cherba, D. M., Anbalagan, A., Winn, M. E., Graveel, C. R., & Sloane, B. F. (2016). Cabozantinib (XL184) inhibits growth and invasion of preclinical TNBC models. Clinical Cancer Research, 22(4), 923–934. https://doi.org/10.1158/1078-0432.CCR-15-0187.CrossRefPubMed

25.

Cavallo-Medved, D., Rudy, D., Blum, G., Bogyo, M., Caglic, D., & Sloane, B. F. (2009). Live-cell imaging demonstrates extracellular matrix degradation in association with active cathepsin B in caveolae of endothelial cells during tube formation. Experimental Cell Research, 315(7), 1234–1246. https://doi.org/10.1016/j.yexcr.2009.01.021.CrossRefPubMedPubMedCentral

26.

Osuala, K. O., Sameni, M., Shah, S., Aggarwal, N., Simonait, M. L., Franco, O. E., Hong, Y., Hayward, S. W., Behbod, F., Mattingly, R. R., & Sloane, B. F. (2015). Il-6 signaling between ductal carcinoma in situ cells and carcinoma-associated fibroblasts mediates tumor cell growth and migration. BMC Cancer, 15, 584. https://doi.org/10.1186/s12885-015-1576-3.CrossRefPubMedPubMedCentral

27.

Jedeszko, C., Sameni, M., Olive, M. B., Moin, K., & Sloane, B. F. (2008). Visualizing protease activity in living cells: from two dimensions to four dimensions. Current Protocols in Cell Biology, 39(1), 4.20.1–4.20. https://doi.org/10.1002/0471143030.cb0420s39.CrossRef

28.

Chalasani, A., Ji, K., Sameni, M., Mazumder, S. H., Xu, Y., Moin, K., et al. (2017). Live-cell imaging of protease activity: assays to screen therapeutic approaches. Methods in Molecular Biology, 1574, 215–225. https://doi.org/10.1007/978-1-4939-6850-3_16.CrossRefPubMed

29.

Ji, K., Mayernik, L., Moin, K., & Sloane, B. F. (2019). Acidosis and proteolysis in the tumor microenvironment. Cancer Metastasis Reviews, 38(1–2), 103–112. https://doi.org/10.1007/s10555-019-09796-3.CrossRefPubMedPubMedCentral

30.

Rothberg, J. M., Bailey, K. M., Wojtkowiak, J. W., Ben-Nun, Y., Bogyo, M., Weber, E., Moin, K., Blum, G., Mattingly, R. R., Gillies, R. J., & Sloane, B. F. (2013). Acid-mediated tumor proteolysis: contribution of cysteine cathepsins. Neoplasia, 15(10), 1125–1137. https://doi.org/10.1593/neo.13946.CrossRefPubMedPubMedCentral

31.

Curino, A. C., Engelholm, L. H., Yamada, S. S., Holmbeck, K., Lund, L. R., Molinolo, A. A., Behrendt, N., Nielsen, B. S., & Bugge, T. H. (2005). Intracellular collagen degradation mediated by uPARAP/Endo180 is a major pathway of extracellular matrix turnover during malignancy. The Journal of Cell Biology, 169(6), 977–985. https://doi.org/10.1083/jcb.200411153.CrossRefPubMedPubMedCentral

32.

Hanahan, D., & Weinberg, R. A. (2011). Hallmarks of cancer: the next generation. Cell, 144(5), 646–674. https://doi.org/10.1016/j.cell.2011.02.013.CrossRefPubMed

33.

Estrella, V., Chen, T., Lloyd, M., Wojtkowiak, J., Cornnell, H. H., Ibrahim-Hashim, A., Bailey, K., Balagurunathan, Y., Rothberg, J. M., Sloane, B. F., Johnson, J., Gatenby, R. A., & Gillies, R. J. (2013). Acidity generated by the tumor microenvironment drives local invasion. Cancer Research, 73(5), 1524–1535. https://doi.org/10.1158/0008-5472.CAN-12-2796.CrossRefPubMedPubMedCentral

34.

Edgington, L. E., Verdoes, M., & Bogyo, M. (2011). Functional imaging of proteases: recent advances in the design and application of substrate-based and activity-based probes. Current Opinion in Chemical Biology, 15(6), 798–805. https://doi.org/10.1016/j.cbpa.2011.10.012.CrossRefPubMedPubMedCentral

35.

Blum, G., Mullins, S. R., Keren, K., Fonovic, M., Jedeszko, C., Rice, M. J., et al. (2005). Dynamic imaging of protease activity with fluorescently quenched activity-based probes. Nature Chemical Biology, 1(4), 203–209. https://doi.org/10.1038/nchembio728.CrossRefPubMed

36.

Withana, N. P., Blum, G., Sameni, M., Slaney, C., Anbalagan, A., Olive, M. B., Bidwell, B. N., Edgington, L., Wang, L., Moin, K., Sloane, B. F., Anderson, R. L., Bogyo, M. S., & Parker, B. S. (2012). Cathepsin B inhibition limits bone metastasis in breast cancer. Cancer Research, 72(5), 1199–1209. https://doi.org/10.1158/0008-5472.CAN-11-2759.CrossRefPubMedPubMedCentral

37.

Duivenvoorden, H. M., Rautela, J., Edgington-Mitchell, L. E., Spurling, A., Greening, D. W., Nowell, C. J., Molloy, T. J., Robbins, E., Brockwell, N. K., Lee, C. S., Chen, M., Holliday, A., Selinger, C. I., Hu, M., Britt, K. L., Stroud, D. A., Bogyo, M., Möller, A., Polyak, K., Sloane, B. F., O'Toole, S. A., & Parker, B. S. (2017). Myoepithelial cell-specific expression of stefin A as a suppressor of early breast cancer invasion. The Journal of Pathology, 243(4), 496–509. https://doi.org/10.1002/path.4990.CrossRefPubMed

38.

Kasperkiewicz, P., Altman, Y., D'Angelo, M., Salvesen, G. S., & Drag, M. (2017). Toolbox of fluorescent probes for parallel imaging reveals uneven location of serine proteases in neutrophils. Journal of the American Chemical Society, 139(29), 10115–10125. https://doi.org/10.1021/jacs.7b04394.CrossRefPubMedPubMedCentral

39.

Heuser, J. (1989). Changes in lysosome shape and distribution correlated with changes in cytoplasmic pH. The Journal of Cell Biology, 108(3), 855–864. https://doi.org/10.1083/jcb.108.3.855.CrossRefPubMed

40.

Rozhin, J., Sameni, M., Ziegler, G., & Sloane, B. F. (1994). Pericellular pH affects distribution and secretion of cathepsin B in malignant cells. Cancer Research, 54(24), 6517–6525.PubMed

41.

Moffat, J. G., Rudolph, J., & Bailey, D. (2014). Phenotypic screening in cancer drug discovery - past, present and future. Nature Reviews. Drug Discovery, 13(8), 588–602. https://doi.org/10.1038/nrd4366.CrossRefPubMed

42.

Yang, Z. Q., Albertson, D., & Ethier, S. P. (2004). Genomic organization of the 8p11-p12 amplicon in three breast cancer cell lines. Cancer Genetics and Cytogenetics, 155(1), 57–62. https://doi.org/10.1016/j.cancergencyto.2004.03.013.CrossRefPubMed

Titel: Spatio-temporal modeling and live-cell imaging of proteolysis in the 4D microenvironment of breast cancer
verfasst von: Kyungmin Ji
Mansoureh Sameni
Kingsley Osuala
Kamiar Moin
Raymond R. Mattingly
Bonnie F. Sloane
Publikationsdatum: 11.10.2019
Verlag: Springer US
Erschienen in: Cancer and Metastasis Reviews / Ausgabe 3/2019
Print ISSN: 0167-7659
Elektronische ISSN: 1573-7233
DOI: https://doi.org/10.1007/s10555-019-09810-8

Springer Medizin

Spatio-temporal modeling and live-cell imaging of proteolysis in the 4D microenvironment of breast cancer

Abstract

Neu im Fachgebiet Onkologie

Labor, CT-Anthropometrie zeigen Risiko für Pankreaskrebs

Viel pflanzliche Nahrung, seltener Prostata-Ca.-Progression

Alter verschlechtert Prognose bei Endometriumkarzinom

Darf man die Behandlung eines Neonazis ablehnen?

Update Onkologie

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 3/2019

Differential roles of protease isoforms in the tumor microenvironment

Functional disparities within the TIMP family in cancer: hints from molecular divergence

The plasminogen activator inhibitor-1 paradox in cancer: a mechanistic understanding

Cell surface–anchored serine proteases in cancer progression and metastasis

Specifically targeting cancer proliferation and metastasis processes: the development of matriptase inhibitors

The role of proteases in epithelial-to-mesenchymal cell transitions in cancer

Neu im Fachgebiet Onkologie

Labor, CT-Anthropometrie zeigen Risiko für Pankreaskrebs

Viel pflanzliche Nahrung, seltener Prostata-Ca.-Progression

Alter verschlechtert Prognose bei Endometriumkarzinom

Darf man die Behandlung eines Neonazis ablehnen?

Update Onkologie